The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
United Agrees To Give Physicians ERISA Rights in Connection with Repayment Demands
Bottom line Recent class action settlement gives all out-of-network (“ONET”) physicians important – and often overlooked – rights under the Employee Retirement Income Security Act of 1974 (“ERISA”) in connection with repayment demands.[1] What is this case about? After paying claims submitted…
Starting an Allergy Practice
The essential tools and pearls for a successful allergy practice by those who have done it! Adding allergy as an ancillary service can be a very rewarding addition to your practice as an otolaryngologist. This is a small guide to…
A Message From AAOA President, Wesley VanderArk, MD, FAAOA
July 2021 marks an almost 18 month journey through COVID. We have witnessed and personally experienced the loss of human lives due to the coronavirus. We have experienced significant shifts in workload and scope of practice and have felt the…
Project N95 Continues to Negotiate Lower Costs
As the challenges of the pandemic change, Project N95 continues to evolve to meet community needs. As our valued partner, AAOA members have access to their pricing and access to necessary medical supplies. Project N95 continues to negotiate lower costs…
2021 ICARS Rhinosinusitis: What You Need To Know
Those interested can still register and stream a video of the webcast at the link below: https://www.workcast.com/register?cpak=2535926321003375 The 2021 update of ICAR: Rhinosinusitis has been recently published in the International Forum of Allergy and Rhinology and many are asking “What…
Targeted Molecular Therapies in Allergy and Rhinology
AAOA's "Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin. The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases. Biologic…
2021 AAOA Annual Meeting – Scientific Abstracts Submissions Now Open
Have novel research tied to allergy, inflammatory disease in ENT, comprehensive management of allergy and inflammatory disease, or another aspect impacting ENT patient care? AAOA is currently soliciting research abstracts for consideration for its Virtual 2021 Annual Meeting. All 2021…
Congress Sends Sesame Labeling Bill To President
By Beth Wang / April 15, 2021 at 11:57 AM The House on Wednesday (April 14) passed a bipartisan bill that will require food makers declare sesame as an allergen on their food labels. The bill, which cleared the Senate in March,…
A Pivotal New Publication on the Role of Biologics
A team led by AAOA Education Coordinator Cecelia Damask, DO, FAAOA, and AAOA President (2018-2019) Matthew Ryan, MD, FAAOA recently published a new supplement to the AAO-HNS OTO Journal on Targeted Molecular Therapies in Allergy and Rhinology. Read More